Physician
Mcdonough Pediatrics
Mcdonough Pediatrics was paid $6.54M by Medicaid between Jan 2018 and Dec 2024, across 70 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.
33Billing provider infoMCDONOUGH PEDIATRICS
MCDONOUGH, GA 30253
MCDONOUGH, GA 30253
33aNPI1669668125assigned 09/19/2007
33bProvider typePediatrics Physician
28Total paid$6.54M
24GClaims213,985
24DCodes billed70
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Georgia
Rank by total paid#13 of 220
Median peer was paid$57K
This provider vs. median114×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28,421 | $1.06M | |
| 2019 | 26,610 | $860K | |
| 2020 | 25,969 | $651K | |
| 2021 | 26,936 | $767K | |
| 2022 | 29,773 | $941K | |
| 2023 | 45,327 | $1.39M | |
| 2024incomplete | 30,949 | $870K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 27,232 | 25,656 | $2.15M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 14,046 | 13,360 | $818K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 10% | 17,341 | 16,788 | $673K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.1% | 7,159 | 6,967 | $594K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.3% | 6,015 | 5,794 | $478K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.2% | 4,613 | 4,471 | $408K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.1% | 7,582 | 7,337 | $268K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.0% | 2,731 | 2,653 | $261K |
| 87428 | 3.6% | 3,546 | 3,481 | $239K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 6,134 | 5,899 | $90K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.3% | 624 | 615 | $85K |
| 85018 | <1% | 17,892 | 17,419 | $51K |
58 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 917 | $47K |
| 99381 | <1% | 464 | $38K | |
| 96127 | <1% | 8,516 | $32K | |
| 99429 | <1% | 2,668 | $31K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,601 | $31K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,169 | $30K |
| 87634 | <1% | 456 | $28K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,034 | $25K |
| 99383 | <1% | 200 | $22K | |
| 81002 | <1% | 6,183 | $17K | |
| 99173 | <1% | 7,263 | $16K | |
| 99384 | <1% | 109 | $13K | |
| 94760 | <1% | 2,476 | $12K | |
| 83655 | <1% | 1,381 | $12K | |
| 96160 | <1% | 4,546 | $11K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 647 | $11K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 55 | $8K |
| 92587 | <1% | 217 | $5K | |
| 80061 | Lipid panel | <1% | 299 | $5K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 101 | $4K |
| 99382 | <1% | 41 | $4K | |
| 0071A | <1% | 124 | $4K | |
| 0072A | <1% | 92 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 186 | $3K |
| 0002A | <1% | 64 | $3K | |
| 92558 | <1% | 6,227 | $2K | |
| 87807 | <1% | 131 | $2K | |
| 0001A | <1% | 52 | $2K | |
| 86756 | <1% | 166 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 12 | $1K |
| 90670 | <1% | 4,855 | $877.20 | |
| 36416 | <1% | 7,762 | $731.82 | |
| 90723 | <1% | 3,592 | $657.90 | |
| 90716 | <1% | 1,422 | $572.78 | |
| 90707 | <1% | 1,340 | $469.03 | |
| 90647 | <1% | 3,017 | $378.96 | |
| 90651 | <1% | 463 | $227.93 | |
| 90633 | <1% | 1,550 | $155.58 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 98 | $48.75 |
| 90734 | <1% | 969 | $21.93 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 15 | $16.99 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 252 | $0.84 |
| 91300 | <1% | 103 | $0.01 | |
| 90700 | 0% | 157 | $0.00 | |
| 90648 | 0% | 183 | $0.00 | |
| 90710 | 0% | 89 | $0.00 | |
| 5250F | 0% | 224 | $0.00 | |
| 90715 | 0% | 284 | $0.00 | |
| 90461 | 0% | 161 | $0.00 | |
| 3008F | 0% | 5,965 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 11,835 | $0.00 |
| 90686 | 0% | 925 | $0.00 | |
| 90680 | 0% | 2,698 | $0.00 | |
| 90696 | 0% | 335 | $0.00 | |
| 91307 | 0% | 296 | $0.00 | |
| 90656 | 0% | 57 | $0.00 | |
| 90620 | 0% | 14 | $0.00 | |
| 90657 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSANKARAN, SEKHAR (PHYSICAN)